OBJECTIVE: The long-term effects of the use of 3,4-methylenedioxymethamphetamine (MDMA, or Ecstasy) in humans are controversial and unclear. The authors' goal was to assess the contribution of a functional polymorphism in the gene encoding serotonin transporter to changes in emotional processing following chronic Ecstasy use. METHOD: They investigated Beck Depression Inventory scores and performance on the Affective Go/No-Go test, a computerized neuropsychological test sensitive to emotional processing, in Ecstasy users and comparison subjects, stratifying the results by serotonin transporter genotype. RESULTS: Ecstasy use was associated with higher Beck Depression Inventory score and abnormalities in the Affective Go/No-Go test in individuals with the ss and ls genotype but not those with the ll genotype. CONCLUSIONS: Ecstasy users carrying the s allele, but not comparison subjects carrying the s allele, showed abnormal emotional processing. On the basis of a comparison with acute tryptophan depletion, the authors hypothesize that chronic Ecstasy use may cause long-term changes to the serotonin system, and that Ecstasy users carrying the s allele may be at particular risk for emotional dysfunction.
OBJECTIVE: The long-term effects of the use of 3,4-methylenedioxymethamphetamine (MDMA, or Ecstasy) in humans are controversial and unclear. The authors' goal was to assess the contribution of a functional polymorphism in the gene encoding serotonin transporter to changes in emotional processing following chronic Ecstasy use. METHOD: They investigated Beck Depression Inventory scores and performance on the Affective Go/No-Go test, a computerized neuropsychological test sensitive to emotional processing, in Ecstasy users and comparison subjects, stratifying the results by serotonin transporter genotype. RESULTS:Ecstasy use was associated with higher Beck Depression Inventory score and abnormalities in the Affective Go/No-Go test in individuals with the ss and ls genotype but not those with the ll genotype. CONCLUSIONS:Ecstasy users carrying the s allele, but not comparison subjects carrying the s allele, showed abnormal emotional processing. On the basis of a comparison with acute tryptophan depletion, the authors hypothesize that chronic Ecstasy use may cause long-term changes to the serotonin system, and that Ecstasy users carrying the s allele may be at particular risk for emotional dysfunction.
Authors: J S Rubinsztein; R D Rogers; W J Riedel; M A Mehta; T W Robbins; B J Sahakian Journal: Psychopharmacology (Berl) Date: 2001-03 Impact factor: 4.530
Authors: L L Carpenter; G M Anderson; G H Pelton; J A Gudin; P D Kirwin; L H Price; G R Heninger; C J McDougle Journal: Neuropsychopharmacology Date: 1998-07 Impact factor: 7.853
Authors: A Richard Green; Annis O Mechan; J Martin Elliott; Esther O'Shea; M Isabel Colado Journal: Pharmacol Rev Date: 2003-07-17 Impact factor: 25.468
Authors: Alexander Neumeister; Anastasios Konstantinidis; Juergen Stastny; Markus J Schwarz; Oliver Vitouch; Matthaus Willeit; Nicole Praschak-Rieder; Johanna Zach; Martina de Zwaan; Brigitta Bondy; Manfred Ackenheil; Siegfried Kasper Journal: Arch Gen Psychiatry Date: 2002-07
Authors: Andrew McLean; Judy S Rubinsztein; Trevor W Robbins; Barbara J Sahakian Journal: Psychopharmacology (Berl) Date: 2003-09-04 Impact factor: 4.530
Authors: Jonathan P Roiser; Robert D Rogers; Lynnette J Cook; Barbara J Sahakian Journal: Psychopharmacology (Berl) Date: 2006-08-29 Impact factor: 4.530
Authors: Abigail A Marsh; Elizabeth C Finger; Beata Buzas; Niveen Soliman; Rebecca A Richell; Meena Vythilingham; Daniel S Pine; David Goldman; R J R Blair Journal: Psychopharmacology (Berl) Date: 2006-09-30 Impact factor: 4.530
Authors: Samanta Yubero-Lahoz; K P C Kuypers; J G Ramaekers; Klaus Langohr; Magí Farré; Rafael de la Torre Journal: Psychopharmacology (Berl) Date: 2014-12-20 Impact factor: 4.530
Authors: Antonio Verdejo-García; Ana Beatriz Fagundo; Aida Cuenca; Joan Rodriguez; Elisabet Cuyás; Klaus Langohr; Susana de Sola Llopis; Ester Civit; Magí Farré; Jordi Peña-Casanova; Rafael de la Torre Journal: Neuropsychopharmacology Date: 2013-02-28 Impact factor: 7.853
Authors: João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho Journal: Mol Neurobiol Date: 2009-04-17 Impact factor: 5.590